title: Effect of infliximab on threatening panuveitis in Behçet's disease.
authors.forename: S
authors.initials: S
authors.lastname: Muñoz-Fernández
authors.forename: V
authors.initials: V
authors.lastname: Hidalgo
authors.forename: J
authors.initials: J
authors.lastname: Fernández-Melón
authors.forename: A
authors.initials: A
authors.lastname: Schlincker
authors.forename: E
authors.initials: E
authors.lastname: Martín-Mola
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D015864:Panuveitis / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D014792:Visual Acuity / Q000187:drug effects
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab